Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes



Rating:

Share or cite this content

Citations should be made in the following way:
T. Raveling (Groningen, Netherlands), J. Vonk (Groningen, Netherlands), H. Kerstjens (Groningen, Netherlands), M. Duiverman (Groningen, Netherlands), P. Wijkstra (Groningen, Netherlands). Chronic NIV in COPD: an exploration of pooled individual patient data. 3567

Member's Comments

No comment yet.

Related content which might interest you: Three practical case studies on COPD using a remote voting system: 2. At hospital: NIV for acute exacerbation of COPD Source: Annual Congress 2013 –Management of COPD with NIV Year: 2013 Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Risk of pneumonia related to budesonide use in COPD: An updated pooled analysis Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012 GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort: Disease management in primary care: Descriptive data Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Exacerbations of COPD: quantifying the patient's perspective using discrete choice modelling Source: Eur Respir J 2005; 26: 623-629 Year: 2005 Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data Source: ERJ Open Res, 6 (4) 00253-2020; 10.1183/23120541.00253-2020 Year: 2020 Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging systems: a pooled analysis of individual patient data Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Readmissions in COPD: The perspective of the patient Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Prediction models for exacerbations in different COPD patient populations: Results of five large databases Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 A comparison of the management of COPD exacerbations in six European hospitals: demographics and baseline data Source: Annual Congress 2008 - Management of COPD Year: 2008 Characteristics of effective self-management interventions in patients with COPD: individual patient data meta-analysis Source: Eur Respir J 2016; 48: 55-68 Year: 2016 Three practical case studies on COPD using a remote voting system: 3. At home: Long-term NIV for stable hypercapnic COPD Source: Annual Congress 2013 –Management of COPD with NIV Year: 2013 European COPD Audit: design, organisation of work and methodology Source: Eur Respir J 2013; 41: 270-276 Year: 2013 Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 COPD in the time of COVID-19: an analysis of acute exacerbations and reported behavioural changes in patients with COPD Source: ERJ Open Res, 7 (1) 00718-2020; 10.1183/23120541.00718-2020 Year: 2021 Prevalence of chronic hypercapnic COPD - preliminary data from the HOmeVent registry Source: International Congress 2017 – New insights in chronic respiratory failure Year: 2017 Effect of high or low-medium accumulated dose regimes of systemic corticosteroids for hospitalised patients with exacerbated chronic obstructive pulmonary disease: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials Source: Virtual Congress 2021 – COPD pharmacology: from basic science to real-world data Year: 2021 Indacaterol/glycopyrronium (IND/GLY) improves lung function irrespective of gender baseline differences in patients with COPD: A pooled analysis from the IGNITE Program Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016